Learn what’s fueling Boston’s biotech investment and partnership opportunities by listening to Xconomy's podcast packaging the highlights from the recent Xcelerating Life Sciences Boston: Biopharma's Future in Digital Health event. Hosted by Xconomy Managing Editor Dan Stanton.

Including expert panels on:

• The convergence of data supporting emerging therapies
• Navigating approaches in a complex regulatory environment
• Managing the patient in the world of personalized medicine
  

Boston already has a proven track record of life science leadership, including emerging therapeutics. Digital technologies will play a critical role in the expansion of this industry and are poised to grow by more than $350 billion alone in the next five years, but significant scientific, technological, financial, and regulatory challenges remain in expanding the ecosystem. What’s already been accomplished and how to handle the hurdles that lie ahead for this shift in focus toward digital health?

Xconomy

2 International Place #2610

Boston, MA 02110-4104